InferRead Series

InferRead® CT Lung

AI Solution for Chest CT

effective for detecting small nodules, comparing nodule development and improve treatment outcomes
FDA
NMPA
UKCA

99%*

sensitivity by AI-assisted reading

*read evidence here

33%*

reduction in reading time

*read evidence here

01

Automatic lung nodule detection

Lung nodule detection for lung cancer screening and opportunistic screening

Pure GGN
Solid Nodule
Suspected Tumor
Mixed GGN

02

Checking for Big 3 diseases

Quantitative imaging of lung nodule growth (an imaging biomarker for lung cancer), emphysema (a type of chronic obstructive pulmonary disease COPD), coronary artery calcification CAC (a biomarker of cardiovascular disease)

CAC
COPD
Lung Nodule
*for investigational use only

03

Intelligent Follow-up

Automated registration of prior and primary CT scans

*VDT: Volume doubling time
For illustration purpose only

Prior Study
Mean diameter(mm):
3.3
Volume(mm3):
19.7

Follow-up Study
Mean diameter(mm):
7.6
Volume(mm3):
300.65

*Not commercially available in all markets

04

Smart structured report

Smart structured report generated automatically and integrated into doctors' workflow.

For illustration purpose only
CEO & Founder of SimonMed

Dr. John Simon

“The utilization of InferRead® CT Lung is another example of SimonMed using the newest technological advancements to improve patient care by helping to provide more accurate diagnoses, including using multi-dimensional analyses to better identify sequential changes in nodules, as well as providing improved detection sensitivity. ”

Managing director at Royal Solutions, former chief information officer at Wake Radiology

Matt Dewey

"The InferRead® CT Lung product enhances radiologists' reading experience, making the detection of nodules faster and less tedious, regardless of their location."

Newsroom

Latest Customer Stories

Get Started with Our Solutions Today

Schedule a live demo and try our solutions